Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 16/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
| ▸ | RICTOR | Q6R327 | 1/20 | 0.30 |
| ▸ | MAPKAP1 | Q9BPZ7 | 1/20 | 0.30 |
| ▸ | MLST8 | Q9BVC4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2808804 | 0.80 | REN (0.55) | RENCYP2D6CYP2C9CYP3A4TSHR | |
| SCHEMBL8004572 | 0.78 | REN (0.42) | RENCYP2D6CYP2C9CYP3A4TSHR | |
| SCHEMBL2805180 | 0.71 | REN (0.48) | RENCYP2D6CYP2C9CYP3A4TSHR | |
| SCHEMBL2339596 | 0.70 | TSHR (0.56) | RENCYP2D6CYP2C9CYP3A4TSHR | |
| SCHEMBL3072690 | 0.69 | REN (0.55) | RENCYP2D6CYP2C9CYP3A4TSHR | |
| SCHEMBL2811094 | 0.69 | REN (0.55) | RENCYP2D6CYP2C9CYP3A4TSHR | |
| SCHEMBL27801717 | 0.69 | REN (0.52) | RENCYP2D6CYP2C9CYP3A4TSHR | |
| SCHEMBL8285646 | 0.69 | BACE1 (0.38) | TSHRALDH1A1 | |
| SCHEMBL2807782 | 0.69 | REN (0.50) | RENCYP2D6CYP2C9CYP3A4TSHR | |
| SCHEMBL3934605 | 0.68 | REN (0.34) | RENCYP2D6CYP2C9CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009106599-A2 | SUBSTITUTED PIPERIDINES AS THERAPEUTIC COMPOUNDS | NOVARTIS AG (CH) | 2009-09-03 | — | — | WO | disclosed |
| WO-2007141318-A1 | 2,5-DISUBSTITUTED PIPERIDINES | SPEEDEL EXPERIMENTA AG (CH) | 2007-12-13 | — | — | WO | disclosed |